Respiratory care startup Telesair raises $22M and more digital health fundings

Telesair, a medical machine firm creating hospital-to-home merchandise for respiratory care, introduced it had raised $22 million in Collection A funding.

The spherical was led by Pasaca Capital with participation from Honeywell Ventures, ZhenCheng Capital, Shangbay Capital, Gadget of Tomorrow Capital, Berkeley Catalyst Fund and Ultrastar Ventures LLC. 

The funding can be used to commercialize its Bonhawa Respiratory Humidifier, designed to be used within the ICU, and assist the event of a brand new product that goals to assist sufferers go away the hospital extra rapidly and keep at residence safely.

“Honeywell is aligned with Telesair’s mission to enhance lives via innovation in digital healthcare,” Patrick Hogan, managing director of Honeywell Ventures, mentioned in a press release. “We’re impressed with their mission and know-how roadmap, and we’re excited to collaborate with them in vital areas resembling superior sensing and distant affected person monitoring, enabled by synthetic intelligence and machine studying.”

ModifyHealth, which delivers medically tailor-made meals and provides digital assist from dietitians, raised $10 million in a Collection B funding spherical led by RC Capital with participation from present investor Nashville Capital Community.

The startup works with sufferers with continual situations like Kind 2 diabetes, hypertension, kidney illness, weight problems and irritable bowel syndrome. Modify, which raised its $2 million Series A in 2020, plans to make use of the funds to assist its development and develop its nationwide operations. 

“Food regimen and life-style play a significant function within the administration of continual well being situations and we’re simply scratching the floor on the influence we are able to make. RCC is a superb match for ModifyHealth and their strategic assist, healthcare experience, and shared imaginative and prescient will assist us ship outcomes extra quickly and broadly,” GB Pratt, founder and CEO of ModifyHealth, mentioned in a press release.

Censinet, developer of healthcare cybersecurity software program, scored $9 million in a funding spherical led by MemorialCare Innovation Fund.

Different contributors within the elevate embody Rex Well being Ventures, Ballad Ventures, LRVHealth, HLM Enterprise Companions, Schooner Capital, Excelerate Well being Ventures and Cedars Sinai. Censinet mentioned the spherical brings its complete funding pot to greater than $22 million. 

“With the variety of breaches escalating and ransomware now a direct risk to affected person security, the necessity for the healthcare business to remodel cyber threat administration has by no means been extra pressing. Censinet’s distinctive threat change permits suppliers, payers and distributors to collaboratively handle third celebration and enterprise threat, repeatedly bettering threat posture in real-time and strengthening cybersecurity throughout all healthcare organizations,” Ed Gaudet, the corporate’s CEO and founder, mentioned in a press release.

Dutch startup Lapsi Well being raised $3.7 million in a seed funding spherical led by Sahir Ali of Modi Ventures.

The corporate is developing digital biomarkers utilizing auscultatory sound, or inside physique sounds from the guts, lungs and stomach. Lapsi will use the capital to proceed to develop their instruments, undergo the FDA and develop into the U.S. market. 

CARI Well being, which is creating a wearable sensor for remedy administration, raised $2.3 million in seed funding. 

The spherical was led by the San Diego Angel Convention (SDAC) with participation from NuFund Enterprise Group, Cove Fund, Chemical Angel Fund, Medical Gadgets of Tomorrow and angel buyers. 

The startup is making a sensor worn on the pores and skin that permits for distant remedy monitoring. If remedy ranges fall outdoors of set pointers, sufferers, members of the family and suppliers can obtain alerts.

The capital will go towards finishing its first human scientific research, increasing its mental property portfolio and planning for a regulatory submission with the FDA. CARI will first give attention to monitoring drugs for opioid use dysfunction (MOUD).

“We’re passionate concerning the potential to make an influence and construct one thing larger than ourselves,” founder and CEO Patrik Schmidle mentioned in a press release. “Wearable distant monitoring can be life-changing for a whole lot of 1000’s of MOUD sufferers, who underneath as we speak’s commonplace of care have to indicate up nearly each day for clinic visits, particularly at first of remedy.”